- Companies
- L'Oreal
L'Oreal Valuation Multiples
L'Oreal is valued at $267B as of November 2026, a 5.4x revenue multiple. In the last 12 months, L'Oreal revenue was $52B and L'Oreal EBITDA was $13B.
L'Oreal Overview
About L'Oreal
L’Oréal is the largest beauty and personal care company globally, generating annual sales of around EUR 44 billion. It has global market share of around 12%, more than twice that of its closest competitor. It competes in essentially every beauty subcategory through four divisions: consumer products, luxe, dermatological beauty, and professional products. Its portfolio is led by L’Oréal Paris, the world’s largest brand in beauty and personal care, alongside about 40 other leading brands. Europe and North America generate more than half of sales. Emerging markets account for less than 20% because L’Oréal classifies North Asia as a developed market, given the maturity of its beauty industry.
Founded
1909
HQ
Employees
95.0K
Website
Sectors
Financials (LTM)
EV
$281B
Valuation Multiples
Start free trialL'Oreal Financials
L'Oreal reported last 12-month revenue of $52B and EBITDA of $13B.
In the same LTM period, L'Oreal generated $39B in gross profit, $13B in EBITDA, and $8B in net income.
Revenue (LTM)
L'Oreal P&L
In the most recent fiscal year, L'Oreal reported revenue of $49B and EBITDA of $11B.
L'Oreal is profitable as of last fiscal year, with gross margin of 74%, EBITDA margin of 24%, and net margin of 14%.
Financial data powered by Morningstar, Inc.
L'Oreal Stock Performance
L'Oreal has current market cap of $267B, and enterprise value of $281B.
Market Cap Evolution
L'Oreal's stock price is $500.03.
L'Oreal share price increased by 2.4% in the last 30 days, and by 14.9% in the last year.
L'Oreal has an EPS (earnings per share) of $12.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $281B | $267B | 0.9% | 2.4% | 11.9% | 14.9% | $12.73 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialL'Oreal Valuation Multiples
L'Oreal trades at 5.4x EV/Revenue multiple, and 22.2x EV/EBITDA.
EV / Revenue (LTM)
L'Oreal Financial Valuation Multiples
As of November 15, 2026, L'Oreal has market cap of $267B and EV of $281B.
L'Oreal has a P/E ratio of 33.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified L'Oreal Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


L'Oreal Margins & Growth Rates
L'Oreal grew revenue by 7% and EBITDA by 10% in the last fiscal year.
In the most recent fiscal year, L'Oreal reported gross margin of 74%, EBITDA margin of 24%, and net margin of 14%.
L'Oreal Margins
L'Oreal Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
L'Oreal Operational KPIs
L'Oreal's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.3M for the same period.
L'Oreal's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
L'Oreal's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
L'Oreal Competitors
L'Oreal competitors include Novo Nordisk, Unilever, Procter & Gamble, EssilorLuxottica, Colgate-Palmolive, Bayer, Galderma, Hindustan Unilever, Reckitt and AbbVie.
Most L'Oreal public comparables operate across Health & Beauty.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $46B | $22B | 4.3x | 4.2x | 8.9x | 8.7x | |||
| $56B | $12B | 3.1x | 3.0x | 14.8x | 13.3x | |||
| $87B | $24B | 4.8x | 4.7x | 17.4x | 17.5x | |||
| $32B | $7.2B | 3.4x | 3.3x | 15.0x | 13.3x | |||
| $20B | $3.9B | 4.2x | 4.0x | 22.1x | 16.8x | |||
| $51B | $3.4B | 2.0x | 1.9x | 29.3x | 9.0x | |||
| $5.2B | $1.1B | 10.5x | 8.7x | 49.2x | 34.1x | |||
| $6.8B | $1.6B | 7.2x | 6.7x | 30.2x | 29.2x | |||
This data is available for Pro users. Sign up to see all L'Oreal competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by L'Oreal
L'Oreal has acquired 27 companies to date.
Last acquisition by L'Oreal was on June 17th 2026. L'Oreal acquired Innovist for undisclosed valuation.
Latest Acquisitions by L'Oreal
| Description | Innovist is an Indian personal care company marketing science-backed products under Bare Anatomy, Chemist At Play, and SunScoop brands. Its portfolio includes customized shampoos for dandruff and hair concerns, body lotions for dryness, and sunscreens for UV protection, available via e-commerce across India. | Creed is a London-headquartered luxury fragrance house founded in 1760, crafting bespoke scents. Bestsellers like Aventus for men and Fleurissimo for women use ingredients such as ginger and pink pepper. The brand also supplies bath gels, lotions, and candles, with Aqua Fiorentina lotion featuring violet and citrus notes. Its fragrances have been worn by royals and celebrities. | Color Wow is a hair care brand offering products for color-treated and damaged hair, including Dream Coat anti-frizz spray, Pop & Lock curl enhancer, and Xtra Large shampoo. Distributed through salons and retailers worldwide, it focuses on salon-quality formulas that extend color vibrancy and manage texture without sulfates or silicones. The brand maintains a presence in professional and consumer markets via its U.S.-based operations. | Medik8 is a London-headquartered skincare manufacturer specializing in vitamin C serums, copper peptide creams, and crystal retinal exfoliants sold via dermatologists and online. The brand's Surface Radiance Cleanse and Barrier Restore Cream feature stabilized actives tested in UK labs for tolerability. Founded in 2010, Medik8 distributes to 40 countries through Dermstore and maintains production in Hertfordshire with a focus on time-released delivery systems. | |
| HQ Country | |||||
| HQ City | New Delhi | London | Bridgeport, CT | London | |
| Deal Date | 17 Jun 2026 | 19 Oct 2025 | 30 Jun 2025 | 9 Jun 2025 | |
| Valuation | undisclosed | $2.7B | $1B | $2.2B | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all L'Oreal acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by L'Oreal
L'Oreal has invested in 10 companies to date.
Latest investment by L'Oreal was on December 8th 2025. L'Oreal invested in Galderma in their $4.9B Secondary round (EV/Revenue multiple available to Pro users).
Latest Investments by L'Oreal
| Description | Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people. | CHANDO is a Shanghai-based skincare brand and the flagship brand of CHANDO Group, formerly JALA Group. It sells skincare, makeup, facial masks, men's grooming and personal care products, many built around Himalayan ingredients and designed for common Chinese skin concerns. | Mahta.bio is a Brazilian food company that sells Amazon superfood products such as shakes, coffee, bars and plant-based Brazil nut milk powder under the idea of regenerative nutrition. It is based in São Paulo. | Sparxell is a Cambridge-based deeptech company that makes plant-based colour technology from cellulose. Its natural, biodegradable pigments replace synthetic pigments in textiles, cosmetics, automotive, packaging and other uses. | |
| HQ Country | |||||
| HQ City | Lausanne | Shanghai | São Paulo | Cambridge | |
| Deal Date | 8 Dec 2025 | 9 Oct 2025 | 19 Aug 2025 | 2 Apr 2024 | |
| Round | Secondary | Undisclosed stage | Seed | Seed | |
| Raised | $4.9B | $104M | $4M | $3M | |
| Investors | L'Oreal | L'Oreal; Harvest Capital | Soros Economic Development Fund; The Brazilian Development Bank(BNDES); Impact Earth; CGIAR Consortium; L'Oreal; ASN Bank | Future Communities Capital; Granatus Ventures; Joyance Partners; Circular Innovation Fund; Snøcap; L'Oreal; Katapult; Earth Venture Capital; PDS Ventures | |
| Valuation | $49B | $1B | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all L'Oreal investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout L'Oreal
| When was L'Oreal founded? | L'Oreal was founded in 1909. |
| Where is L'Oreal headquartered? | L'Oreal is headquartered in France. |
| How many employees does L'Oreal have? | As of today, L'Oreal has over 95K employees. |
| Who is the CEO of L'Oreal? | L'Oreal's CEO is Nicolas Hieronimus. |
| Is L'Oreal publicly listed? | Yes, L'Oreal is a public company listed on Euronext Paris. |
| What is the stock symbol of L'Oreal? | L'Oreal trades under OR ticker. |
| When did L'Oreal go public? | L'Oreal went public in 1989. |
| Who are competitors of L'Oreal? | L'Oreal main competitors include Novo Nordisk, Unilever, Procter & Gamble, EssilorLuxottica, Colgate-Palmolive, Bayer, Galderma, Hindustan Unilever, Reckitt, AbbVie. |
| What is the current market cap of L'Oreal? | L'Oreal's current market cap is $267B. |
| What is the current revenue of L'Oreal? | L'Oreal's last 12 months revenue is $52B. |
| What is the current revenue growth of L'Oreal? | L'Oreal revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of L'Oreal? | Current revenue multiple of L'Oreal is 5.4x. |
| What is the current EBITDA of L'Oreal? | L'Oreal's last 12 months EBITDA is $13B. |
| What is L'Oreal's EBITDA margin? | L'Oreal's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of L'Oreal? | Current EBITDA multiple of L'Oreal is 22.2x. |
| What is the current FCF of L'Oreal? | L'Oreal's last 12 months FCF is $8.2B. |
| What is L'Oreal's FCF margin? | L'Oreal's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of L'Oreal? | Current FCF multiple of L'Oreal is 34.4x. |
| How many companies L'Oreal has acquired to date? | As of November 2026, L'Oreal has acquired 27 companies. |
| What was the largest acquisition by L'Oreal? | $2.7B acquisition of Creed on 19th October 2025 was the largest M&A L'Oreal has done to date. |
| What companies L'Oreal acquired? | L'Oreal acquired Creed, Aesop, Medik8, CeraVe, IT Cosmetics, Color Wow, Dr.G, Pulp Riot, NYX Cosmetics, Thayers Natural Remedies, and 17 other companies. |
| In how many companies L'Oreal has invested to date? | As of November 2026, L'Oreal has invested in 10 companies. |
| What was the last L'Oreal investment? | On 8th December 2025 L'Oreal invested in Galderma, participating in a $4.9B Secondary round at $49B valuation. |
| In what companies L'Oreal invested in? | L'Oreal invested in Galderma, Chando, NetZero, BeautyCon, Digital Village, Mahta.bio, Rize ag, Sparxell, Poplar Studio, and The Sabi. |
See public comps similar to L'Oreal
Lists including L'Oreal
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




